CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid‑in Capital	Accumulated other comprehensive loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020	85,299,885
Beginning balance at Dec. 31, 2020	$ 81,658
Redeemable Convertible Preferred Stock
Issuance of Series B redeemable convertible preferred stock, net of issuance costs of $420 (in shares)	53,522,099
Issuance of Series B redeemable convertible preferred stock, net of issuance costs of $420	$ 115,831
Conversion of redeemable convertible preferred stock upon initial public offering (in shares)	(138,821,984)
Conversion of redeemable convertible preferred stock upon initial public offering	$ (197,489)
Ending balance (in shares) at Dec. 31, 2021	0
Ending balance at Dec. 31, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020		1,244,139
Beginning balance at Dec. 31, 2020	(41,490)	$ 0	$ 1,021	$ 0	$ (42,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock upon initial public offering (in shares)		19,185,183
Conversion of redeemable convertible preferred stock upon initial public offering	197,489	$ 2	197,487
Issuance of common stock from initial public offering, net of issuance costs of $18,034 (in shares)		10,436,250
Issuance of common stock from initial public offering, net of issuance costs of $18,034	190,691	$ 1	190,690
Issuance of common stock upon exercise of stock options (in shares)		223,838
Issuance of common stock upon exercise of stock options	$ 410		410
Vesting of restricted common stock (in shares)		11,537
Vesting of early exercised options (in shares)	111,756	123,389
Vesting of early exercised options	$ 250		250
Stock‑based compensation	2,526		2,526
Total other comprehensive loss	0
Net loss	$ (51,158)				(51,158)
Ending balance (in shares) at Dec. 31, 2021	31,224,336	31,224,336
Ending balance at Dec. 31, 2021	$ 298,718	$ 3	392,384	0	(93,669)
Ending balance (in shares) at Dec. 31, 2022	0
Ending balance at Dec. 31, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		84,526
Issuance of common stock upon exercise of stock options	$ 195		195
Vesting of early exercised options (in shares)	53,741	58,015
Vesting of early exercised options	$ 135		135
Purchase of common stock under the employee stock purchase plan (in shares)		27,890
Purchase of common stock under the employee stock purchase plan	284		284
Stock‑based compensation	9,895		9,895
Total other comprehensive loss	(2,057)			(2,057)
Net loss	$ (94,616)				(94,616)
Ending balance (in shares) at Dec. 31, 2022	31,394,767	31,394,767
Ending balance at Dec. 31, 2022	$ 212,554	$ 3	$ 402,893	$ (2,057)	$ (188,285)